Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026?
One-OffHealth & Medicine3mFutuurDatos de resolución verificadosProbabilidad implícita actualNo 93%
Calidad del mercado
31 / 100
Baja calidadVolumen 24h
—
Liquidez
308,4 €
Baja liquidezTraders
8
Comentarios
0
Datos de mercado
Actualizado hace 1 minuto
Tendencias
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
Will artificial blood be used to treat a patient by the end of 2026?
Manifold MarketsBumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026?
FutuurWill artificial blood be used to treat a patient by the end of 2027?
Manifold MarketsHow many patients will be treated under right-to-try in Montana within 2026?
FutuurPeer-reviewed paper in 2026 shows mycelial compounds effective against respiratory diseases?
Manifold MarketsWill Artificial wombs for premature babies be tested in humans by the end of 2026?
FutuurReglas
Los criterios de resolución aún no están disponibles para este mercado. Las próximas actualizaciones completarán esta sección cuando se hayan guardado las reglas de la fuente.
Mercados abiertos
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volumen total
- 15,6 M €
- Volumen 24h
- 18,3 mil €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Volumen total
- 1,6 M €
- Volumen 24h
- 5,2 mil €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 resultados más
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Volumen total
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Volumen total
- 916 mil €
- Volumen 24h
- 1,5 mil €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 resultados más
- Volumen total
- 863,6 mil €
- Volumen 24h
- 1 mil €
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
Preguntas frecuentes
- ¿Cuáles son las probabilidades actuales de Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026??
- Futuur cotiza No al 93% a fecha de 8 de septiembre de 2026.
- ¿Cuándo se resuelve Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026??
- Está previsto que Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026? se resuelva el 31 de diciembre de 2026.